Royce & Associates’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding LFMD
PGCM
BRF
Royce & Associates's LFMD Position: Q2 2026 in Review
Royce & Associates reduced its LifeMD (LFMD) stake by 47% in Q2 2026, selling an estimated $2.5M and leaving 636,124 shares worth $2.63M. The position accounts for 0.02% of the portfolio, ranked #574.
Royce & Associates first reported a position in LFMD in Q2 2022 and has held it in 17 quarters since. The position peaked at $10.5M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.
- Royce & Associates held 636,124 shares of LifeMD worth $2.63M as of Q2 2026.
- Royce & Associates sold 565,527 LifeMD shares in Q2 2026, an estimated $2.5M.
- LifeMD made up 0.02% of Royce & Associates's portfolio in Q2 2026, its #574 holding.
- Royce & Associates first reported a position in LifeMD in Q2 2022 and has held it in 17 quarters since.
- Royce & Associates's LifeMD position peaked at $10.5M in Q2 2025.
- 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.